CORT - Corcept Therapeutics Incorporated

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue251,247159,20181,32150,286
Cost of Revenue5,2153,5542,0581,361
Gross Profit246,032155,64779,26348,925
Operating Expenses
Research Development75,24740,37623,84415,419
Selling General and Administrative81,28962,41645,24036,949
Non Recurring----
Others----
Total Operating Expenses161,751106,34671,14253,729
Operating Income or Loss89,49652,85510,179-3,443
Income from Continuing Operations
Total Other Income/Expenses Net2,657-49-2,039-2,965
Earnings Before Interest and Taxes89,49652,85510,179-3,443
Interest Expense--500-2,039-2,965
Income Before Tax92,15352,8068,140-6,408
Income Tax Expense16,743-76,316--
Minority Interest----
Net Income From Continuing Ops75,410129,1228,140-6,408
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income75,410129,1228,140-6,408
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares75,410129,1228,140-6,408